Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (141-150 of 224) with videos related to

Pageof 23
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphomaGeorg Feldmann, Hans Dieter Nischalke, Jacob Nattermann, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, et al.
The Journal of Infectious Diseases|September 29, 2009
The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cellsDaniela Schulte, Martin Vogel, Bettina Langhans, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 2015
The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascitesPhilipp Lutz, Kenneth Pfarr, Hans Dieter Nischalke, et al.
International Journal of Cancer|April 19, 2011
The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis CHans-Dieter Nischalke, Martin Coenen, Cordula Berger, et al.
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patientsThomas Berg, Viola Weich, Gerlinde Teuber, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patientsPavlos Kokordelis, Benjamin Krämer, Christian Körner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 7, 2019
The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical InterventionsLeah Maria Klein, Johannes Chang, Wenyi Gu, et al.
Plos One|April 6, 2017
Alterations of the NK cell pool in HIV/HCV co-infectionDominik J Kaczmarek, Pavlos Kokordelis, Benjamin Krämer, et al.
Pageof 23

Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphomaGeorg Feldmann, Hans Dieter Nischalke, Jacob Nattermann, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, et al.
The Journal of Infectious Diseases|September 29, 2009
The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cellsDaniela Schulte, Martin Vogel, Bettina Langhans, et al.
Clinical Chemistry and Laboratory Medicine|June 3, 2015
The ratio of calprotectin to total protein as a diagnostic and prognostic marker for spontaneous bacterial peritonitis in patients with liver cirrhosis and ascitesPhilipp Lutz, Kenneth Pfarr, Hans Dieter Nischalke, et al.
International Journal of Cancer|April 19, 2011
The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis CHans-Dieter Nischalke, Martin Coenen, Cordula Berger, et al.
Journal of Hepatology|December 17, 2011
The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patientsHans Dieter Nischalke, Cordula Berger, Carolin Luda, et al.
Hepatology (Baltimore, Md.)|July 4, 2009
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patientsThomas Berg, Viola Weich, Gerlinde Teuber, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patientsPavlos Kokordelis, Benjamin Krämer, Christian Körner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 7, 2019
The Development and Outcome of Acute-on-Chronic Liver Failure After Surgical InterventionsLeah Maria Klein, Johannes Chang, Wenyi Gu, et al.
Plos One|April 6, 2017
Alterations of the NK cell pool in HIV/HCV co-infectionDominik J Kaczmarek, Pavlos Kokordelis, Benjamin Krämer, et al.
Pageof 23